Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06095375
Title Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients (REGOMA-2)
Acronym REGOMA-2
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Istituto Oncologico Veneto IRCCS
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA

Facility Status City State Zip Country Details
Istituto Oncologico Veneto IRCCS RECRUITING Padova 35128 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field